The World Health Organization said Monday that it had "temporarily" suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.
The decision came after the publication last week of a study in the Lancet indicating that the using the drug on COVID-19 patients could increase their likelihood of dying, WHO chief Tedros Adhanom Ghebreyesus told a virtual press conference, adding that the WHO-backed trials had been "suspended while the safety is reviewed."
'Pornoextortion': Former Argentina Forward Ezequiel Lavezzi Makes Sex Video Blackmail Complaint
Just Wanted To See His Dying Son: Story Behind Photograph Of Crying Man That Shook India
Detained Briefly By Delhi Police After Meeting Rahul Gandhi, Migrants Get Cong Help
The Lockdown Failed On All Fronts. There's No Other Way Of Saying It
World Hepatitis Day 2019: Hepatitis Has Become One Of The Pressing Public Health Concerns In India
How Much Would You Pay For A Kidney?
Covid-19 Cases In India Likely To Peak In Early July: Health Economist Dr Ramanan Laxminarayan
Cyclone Amphan Was Terrible. It Could Have Been Worse